US Stock MarketDetailed Quotes

PRQR ProQR Therapeutics

Watchlist
  • 1.9300
  • +0.0700+3.76%
Close Jul 31 16:00 ET
157.61MMarket Cap-5406P/E (TTM)

ProQR Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ProQR Therapeutics Earnings Date

Currency: EUR

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

4.45M

+579.39%
EPS(YoY)

-0.09

+18.18%
Analyst Rating

Strong Buy

Jul 31, 2024

ProQR Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 3.414M--
--2024/Q2-- / 11.158M--
--2024/Q15.021M / 2.857M--
--2023/Q46.786M / 15.902M--
--2023/Q31.472M / 3.647M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 3.414M--
--2024/Q2-- / 11.158M--
--2024/Q15.021M / 2.857M--
--2023/Q46.786M / 15.902M--
--2023/Q31.472M / 3.647M--

Unlock Free Earnings Estimates

ProQR Therapeutics Earnings Reports

  • ProQR Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    May 9 07:07 ET

  • ProQR Therapeutics | 20-F: Registration statement / Annual report / Transition report

    Mar 13 08:48 ET

  • ProQR Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 7, 2023 10:00 ET

  • ProQR Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 3, 2023 07:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 31, 2024

    Strong Buy

    • Buy

      75.00%

    • Hold

      25.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg